The translational solutions that InforSense provides will enable us to have an integrated data set under a common system that informaticians, researchers and clinicians can all use to access and analyze data. This will result in improved data sharing and removal of access bottlenecks, speeding up the speed and accuracy of novel biomarker identification.

Simon Lovestone, Professor of Old Age Psychiatry at King’s College London and Director of the Biomedical Research Centre for Mental Health

The InforSense Virtual Machine gives us the power and flexibility to support the changing requirements of our customers.

Andreas Hühmer, Proteomics Marketing Director, Thermo Fisher Scientific

SIMDAT has enabled us to test out all the components we need to support the virtual outsourcing of data analysis in a secure environment. The combination of NEC internet security models, InforSense workflows, GRIA service-oriented infrastructure and data analysis services from BioFocus DPI and Université Libre de Bruxelles has shown how virtual organizations can become a reality.

Rob Gill, Head of Biology Domain Architecture at GSK

We have been working with InforSense for many years in our bioinformatics department, to provide services to other departments in the University, particularly for gene expression analysis.

Professor Nabeel Affara, Department of Pathology, University of Cambridge

We have selected the InforSense Translational Research Solution because it provides advanced data integration and ETL capabilities, combined with analytical power and process flexibility. Using this solution, analyses can be quickly developed, modified and deployed via a web interface that is easily used by our scientists.

John Quackenbush, Ph.D., Professor of Biostatistics and Computational Biology, Dana-Farber Cancer Institute

We can integrate Patient Data from our Laboratory Information System with Insurance Information from our billing system and automatically generate reports on a monthly basis. These reports are used by Martin’s Point for their PointPartners Health System to improve the health and well being of patients.

Denis Rochette, Director IT, NorDx

We have selected the InforSense 5.0 Translational Research Solution because it provides the integration capabilities we need with out-of-the-box analytical workflows and user interfaces for translational research. In addition, the InforSense 5.0 platform gives us the power and process flexibility to quickly develop our own best practice analysis workflows and deploy them, via a web interface, to our scientists.

Prof. Peter van der Spek, Ph. D., Head of Erasmus Center for Bioinformatics, Erasmus MC

InforSense provides an easy and flexible analytic solution to the Bank. It has been invaluable to us in implementing the data modeling necessary for Basel II compliance, risk management, as well as the complex coordination amongst various departments required for our Anti-Money Laundering initiatives.

Anthony Wu, Director & Assistant General

InforSense’s proven multi-platform integration will enable us to exploit our existing informatics investment and provide a highly extensible discovery environment for the future.

Herbert Köppen, Head of Chemoinformatics, Boehringer Ingelheim

InforSense is the only supplier to offer such a highly open, flexible and scalable integrative informatics environment. This is the initial step to fulfill our vision of delivering automated integration, analysis and interpretation of diverse data for the benefit of our entire scientific and technical community.

Yixue Li, General Project Leader of the Shanghai Public Infrastructure for Research and Development Service, Shanghai Public Infrastructure for Research and Development Service

After a thorough and competitive analysis, we selected InforSense software because, right out-of-the-box, it delivers a core of research-relevant, integrative analytic capabilities that give us an information advantage in novel agricultural discovery. In addition, InforSense’s Professional Services group demonstrated its ability to help us efficiently customize the solution to fit into our existing data management processes and infrastructure.

Dr. John Chan, Syngenta’s Head of Global Bioinformatics

We are pleased to be working with InforSense again, having proved the value of their text-mining technology to our business. TextSense's flexible workflow-centric approach enables us to capture knowledge without dictating the process, empowering end-users to solve real research challenges.

Lawrence Barratt, Head of Knowledge and Information Sciences at Unilever R&D Colworth

InforSense workflow technology will enable us to build solutions that are flexible enough to support the dynamic and iterative thought processes of our scientists. Combined with the ability to then deploy these findings throughout our research teams, InforSense technology will enable our scientists to translate their research into real decisions that can impact patient care.

Prof. Michael Liebman, CSO, Windber Research Institute